Featured
Last news
Medical Care Technologies (OTC PINK:MDCE) Advances AI Research to Help Identify Early Health Risks in Skin Cancer, Vision, Wound Care, and Mental Wellness
MESA, ARIZONA / ACCESS Newswire / October 9, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), a developer of artificial intelligence-powered preventive health technology, today emphasized the urgent human need driving each vertical of its AI platform - underscoring the global lives lost and affected every year to conditions that may be better managed through earlier detection and awareness.
Lexaria Bioscience Corp. Provides Strategic Update
Strategic Business Development Advisory Firm Engaged To Support New Business Development ActivitiesLexaria Awarded 4 New Patents
iTolerance, Inc. Launches Patient Journey Series Highlighting the Real-Life Impact of Type 1 Diabetes
Watch the first video segment here
Xcelerate, Inc. Announces the Sale of its Majority Interest in ESN Group
MAULDIN, SC / ACCESS Newswire / October 9, 2025 / Xcelerate, Inc. (OTC Markets:XCRT) today announced the sale of its majority interest in the ESN Group of companies, including ESN Group, Inc. and California Skin Research, Inc to Noble Labs Holdings, LLC, a company that had previously provided funding and marketing support to ESN Group, Inc. The transaction was completed as an all-cash sale.
Who is the Best Female to Male Top Surgeon?
Dr. Javad Sajan is the best female to male top surgeon
Stemtech Corporation Announces Exclusive Taiwan Distribution Licensing Agreement
NAPLES, FL, AL / ACCESS Newswire / October 9, 2025 / Stemtech Corporation, the global leader and pioneer in stem cell nutrition, is proud to announce an exclusive distribution agreement with Energy International Development Co., Ltd. to sell Stemtech products in Taiwan, R.O.C.
New to The Street Signs PetVivo Holdings Inc. (OTCQX:PETV) to a 12-Month National Media Campaign
Partnership Includes Long-Form Broadcast Interviews, National TV Commercials, Outdoor Billboards, and Accredited Investor Events
Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections
FORT LAUDERDALE, FL / ACCESS Newswire / October 9, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has developed a new series of orally active, non-covalent protease inhibitors with dose-dependent antiviral activity in mice infected with SARS Coronavirus (SARS-CoV-2). This work was carried out at the University of Arizona as part of an ongoing collaboration between the Company and the University.
Sensi.AI Raises $45M Series C, Extending Its Dominance of Care Intelligence in Vertical AI
Serving 80% of the largest home care networks across North America, Sensi.AI is the new standard in senior care
United Premium Foods Taps Tosca Reusable Packaging to Meet Rising Demand for Fresh Pet Food
United Premium Foods leverages Tosca's reusable pet food packaging to cut labor strain, protect product, and streamline coast-to-coast delivery.
Pawsible Ventures Launches $10M Fund and Venture Studio to Build the Next Generation of Animal Wellness Companies
Backed by Victory Square, Pawsible combines capital, incubation, and distribution to accelerate diagnostics, AI, insurance, and wellness innovation in the $250B+ global pet economy.
New Product of The Year Awards and Guided Exhibit Floor Tours to Headline the 2025 Assembly Show
Attendees Invited to Vote on the Industry's Top Innovations
Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells
New findings show Telomir-1 shuts down cellular energy pathways and mitochondrial function in aggressive breast cancer cells, leading to cell death through iron-dependent regulation.
Bausch Health Announces Results of Special Meeting of Shareholders
LAVAL, QC / ACCESS Newswire / October 9, 2025 / Bausch Health Companies Inc. (the "Company") (NYSE:BHC)(TSX:BHC) today announced the results of the special meeting of shareholders held on October 7, 2025 (the "Shareholders Meeting"). At the Shareholders Meeting, shareholders of the Company approved the ratification, confirmation and approval of the adoption of the Company's Amended and Restated Shareholder Rights Plan Agreement dated April 14, 2025, as amended and restated on August 25, 2025 (the "Rights Plan Agreement"), as described in detail in the Company's Management Proxy Circular and Proxy Statement dated August 27, 2025.
Zomedica to Spotlight VETGuardian(R) Zero Touch(TM) Monitor in October "Fourth Friday at Four" Webinar
Live session on October 24th will showcase how the VETGuardian Monitor enhances patient care, improves workflow efficiency, and expands global market opportunities
EX DEA Administrator Anne Milgram's "Swampy" Legacy: No-Bid Contracts, No Marijuana Reform, and No Accountability
MMJ BioPharma CEO Duane Boise summed it up bluntly:"Milgram's DEA was a monument to incompetence and indifference - and patients paid the price. Every day of delay meant another day people with Huntington's and Multiple Sclerosis went without hope. Terry Cole now has the chance to fix what she broke."
KFC’s Secret Recipe is Out - The One the World Really Needs
JOHANNESBURG, ZA / ACCESS Newswire / October 9, 2025 / KFC Africa's ( http://KFC.co.za ) big secret is out, and no, it's not the blend of 11 herbs and spices, it's a recipe of hope to end child hunger - open-sourced globally for sharing and scaling in honour of World Food Day.
BioNxt Completes "Fast-Track" US Track One Patent Filing for Sublingual Delivery of Cladribine for the Treatment of Multiple Sclerosis
VANCOUVER, BC / ACCESS Newswire / October 9, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in next-generation drug delivery technologies, today announced that it has completed a Track One priority patent filing with the U.S. Patent and Trademark Office (USPTO) for its proprietary sublingual thin-film cladribine formulation (BNT23001), designed for the treatment of multiple sclerosis (MS). The Track One patent filing also covers sublingual drug products for the treatment of many other neurological autoimmune diseases, including myasthenia gravis and lupus nephritis.
Genflow Biosciences PLC Announces Update, Equity Issue and PDMR Notification
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.Termination of Initial Transaction, Subscription of New Ordinary Shares, Warrant Issue and PDMR Dealings
Suspect in US court months after deadly Los Angeles fire
A man suspected of deliberately causing one of the deadliest fires in US history appeared in court Wednesday charged with sparking a blaze that tore through Los Angeles in January.
Man arrested over deadly January fire in Los Angeles
Authorities investigating one of the deadly fires that tore through Los Angeles in January said Wednesday they had arrested a man they believe deliberately started the blaze.
Gisele Pelicot urges accused rapist to 'take responsibility'
Gisele Pelicot, the Frenchwoman who became a feminist hero in a mass rape trial last year, was thrust into the national spotlight once again Wednesday, telling the one man who still denies raping her he must "take responsibility" for his actions.
Far right harvests votes as climate rules roil rural Spain
Standing by a barn brimming with hundreds of bleating sheep, Jesus del Socorro Cuevas leads the far right's charge against "dictatorial" EU environmental regulation in his corner of rural Spain.
Australia police foil 'kill team' gang hit near daycare centre
Australian police foiled an alleged organised crime hit by a so-called kill team near a Sydney daycare facility, authorities said Wednesday.
Trump unlikely to win Nobel Peace Prize, but who will?
When it comes to this year's Nobel Peace Prize, one thing is almost certain: US President Donald Trump will not win, no matter how much he wants it. But who will?
Two bodies found, two missing after Madrid building collapse
Spanish emergency services have found two bodies buried in the rubble after a building under construction collapsed in central Madrid Tuesday, with two more people still missing and several workers injured, authorities said.
Happy Holidays! RuffleButts Launches Their Full-Family Christmas Collection
Beat the holiday rush and get ready for Christmas early with RuffleButts new family matching PJ and apparel collection.
Louisiana Breeder Represents State in the 2025 Pet Care Community Fly-in in Washington, D.C.
Victor McShan of Amite, Louisiana, traveled to Washington, D.C. as the official delegate representing dog breeders for the State of Louisiana at the 2025 Pet Care Community D.C Fly-In with the Breeder Leadership Council (BLC).
Nashville's Fashion Moment: MAGIC October Edition Showcases Tomorrow's Western-Inspired Trends
NASHVILLE, TN / ACCESS Newswire / October 8, 2025 / MAGIC, successfully concluded its latest Nashville edition on October 3, 2025, reinforcing its position as the ultimate fashion industry event for the trend-driven retailers, buyers and industry leaders in the Southeast region. As the premier wholesale fashion event for contemporary, young contemporary and trend women's wear, this high-energy event brought together leading brands and retailers to preview Spring/Summer 2026 collections with a distinctive focus on western wear, gameday fashion, and immediate delivery items.
Duly Health and Care Physicians Now Offering Access to Galleri(R) Multi-Cancer Early Detection Test
DOWNERS GROVE, IL / ACCESS Newswire / October 8, 2025 / Duly Health and Care, through its Chicagoland medical group, DuPage Medical Group, LTD., is now offering access to the Galleri® multi-cancer early detection (MCED) test, a groundbreaking tool designed to screen for a signal shared by more than 50 types of cancer -- many of which currently have no recommended screening tests.
Medical Care Technologies (OTC PINK:MDCE) Initiates Preparatory Phase for Self-Conducted Research Studies on AI Mental Health and Preventive Biometrics Modules
MESA, ARIZONA / ACCESS Newswire / October 8, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), an emerging innovator in AI-powered preventive healthcare, announced that it is preparing to conduct internal, non-clinical research studies on the consumer-facing components of its AI health platform - the Mental Health & Micro-Expression Tracker and the Preventive Health & Facial Biometrics Analyzer.
Dolphin CEO Bill O'Dowd Named to PRNEWS 2025 People of the Year List; Company Recognized on Agency Elite 120
MIAMI, FLORIDA / ACCESS Newswire / October 8, 2025 / Last night in New York City, Dolphin (NASDAQ:DLPN) celebrated the recognition of its Founder and CEO, Bill O'Dowd, who was named to the PRNEWS 2025 People of the Year list, honoring the industry's most innovative and influential leaders. At the same time, Dolphin was recognized on the PRNEWS Agency Elite 120, a prestigious ranking of the top communications, PR, and marketing firms shaping the future of the industry.